Skip to main content
Back
Watch Compare

KALA BIO, Inc.

Data quality: 83%
KALA
Nasdaq Manufacturing Chemicals
$0.20
▲ $0.02 (10.93%)
Mkt Cap: 166.32 M
Price
$0.18
Mkt Cap
166.32 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -32.03 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-485.93%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio0.75
Interest Coverage-8.48

Valuation

PE (TTM)
-4.64
Below sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -4.6 -1.5
P/B — 1.6
ROE % — -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q32025 -$1.01 -$1.07 -5.9%
Q22025 -$2.04 -$1.32 +35.4%
Q12025 -$2.54 -$1.01 +60.1%
Q42024 -$2.47 -$1.23 +50.1%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -35.84 M
ROE N/A ROA -117.37%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -32.03 M
ROIC -485.93% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.75
Interest Coverage -8.48 Asset Turnover N/A
Working Capital -8.30 M Tangible Book Value -8.67 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.64 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -19.26%
Market Cap 166.32 M Enterprise Value 172.17 M
Per Share
EPS (Diluted TTM) -5.64 Revenue / Share N/A
FCF / Share -0.04 OCF / Share -0.04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 89.38%
SBC-Adj. FCF -40.66 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -38.51 M -42.20 M -44.82 M -142.61 M -104.33 M
EPS (Diluted) -10.15 -17.35 -29.48 -2.19 —
Gross Profit — — — — —
Operating Income -40.98 M -39.66 M -81.71 M -130.25 M -96.23 M
EBITDA — — — — —
R&D Expenses — — — — 18.35 M
SG&A Expenses — 20.57 M 65.04 M 105.06 M 81.07 M
D&A 259,000.0 303,000.0 537,000.0 975,000.0 912,000.0
Interest Expense 5.78 M 5.81 M 7.27 M 8.38 M 8.59 M
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 55.48 M 55.95 M 86.82 M 139.43 M 221.61 M
Total Liabilities 43.15 M 48.45 M 67.85 M 122.62 M 121.61 M
Shareholders' Equity 12.33 M 7.50 M 18.97 M 16.80 M 100.00 M
Total Debt 20.10 M 34.19 M 43.30 M 80.00 M 75.00 M
Cash & Equivalents 51.18 M 50.90 M 70.50 M 92.14 M 77.26 M
Current Assets 52.80 M 52.87 M 85.94 M 124.37 M 171.38 M
Current Liabilities 16.96 M 8.35 M 25.69 M 37.42 M 22.23 M